LY-3056480

N/A

Report date: 2022/08/26 20:00:45
NME

Base Information

Drug NameLY-3056480
Drug Alias NameLY-3056480
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasopressin V1a receptor agonists
TargetsVasopressin V1a receptor
Therapy Area/IndicationsHearing Loss, Sensorineural
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAudion Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAudion Therapeutics
Active IndicationsN/A
Inactive IndicationsHearing Loss, Sensorineural

Other Information

ATC CodeN/A
Related LinksN/A